Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

12,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Kakizoe M, Yao M, Tateishi U, Minamimoto R, Ueno D, Namura K, Makiyama K, Hayashi N, Sano F, Kishida T, Kobayashi K, Noguchi S, Ikeda I, Ohgo Y, Taguri M, Morita S, Inoue T, Kubota Y, Nakaigawa N. Kakizoe M, et al. Among authors: kobayashi k. BMC Cancer. 2014 Jun 2;14:390. doi: 10.1186/1471-2407-14-390. BMC Cancer. 2014. PMID: 24885730 Free PMC article.
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
Nakaigawa N, Kondo K, Tateishi U, Minamimoto R, Kaneta T, Namura K, Ueno D, Kobayashi K, Kishida T, Ikeda I, Hasumi H, Makiyama K, Kubota Y, Inoue T, Yao M. Nakaigawa N, et al. Among authors: kobayashi k. BMC Cancer. 2016 Feb 8;16:67. doi: 10.1186/s12885-016-2097-4. BMC Cancer. 2016. PMID: 26857818 Free PMC article.
The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
Nakaigawa N, Kondo K, Ueno D, Namura K, Makiyama K, Kobayashi K, Shioi K, Ikeda I, Kishida T, Kaneta T, Minamimoto R, Tateishi U, Inoue T, Yao M. Nakaigawa N, et al. Among authors: kobayashi k. BMC Cancer. 2017 Jan 9;17(1):39. doi: 10.1186/s12885-016-3044-0. BMC Cancer. 2017. PMID: 28068944 Free PMC article.
Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.
Tabei T, Nakaigawa N, Kaneta T, Ikeda I, Kondo K, Makiyama K, Hasumi H, Hayashi N, Kawahara T, Izumi K, Osaka K, Muraoka K, Teranishi JI, Miyoshi Y, Yumura Y, Uemura H, Kobayashi K, Inoue T, Yao M. Tabei T, et al. Among authors: kobayashi k. BMC Cancer. 2019 Apr 2;19(1):298. doi: 10.1186/s12885-019-5510-y. BMC Cancer. 2019. PMID: 30940117 Free PMC article. Clinical Trial.
A rare case of isolated splenic sarcoidosis: A case report and literature review.
Kobayashi K, Einama T, Fujinuma I, Tsunenari T, Miyata Y, Iwasaki T, Asakuma J, Soga S, Shinmoto H, Tsujimoto H, Hase K, Ueno H, Kishi Y. Kobayashi K, et al. Mol Clin Oncol. 2021 Feb;14(2):22. doi: 10.3892/mco.2020.2184. Epub 2020 Dec 3. Mol Clin Oncol. 2021. PMID: 33335730 Free PMC article.
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma.
Takihata Y, Einama T, Kobayashi K, Suzuki T, Yonamine N, Fujinuma I, Tsunenari T, Yamagishi Y, Iwasaki T, Miyata Y, Shinto E, Ogata S, Tsujimoto H, Ueno H, Kishi Y. Takihata Y, et al. Among authors: kobayashi k. Oncol Lett. 2021 May;21(5):414. doi: 10.3892/ol.2021.12675. Epub 2021 Mar 23. Oncol Lett. 2021. PMID: 33841575 Free PMC article.
Erratum: Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report.
Sota Y, Einama T, Kobayashi K, Fujinuma I, Tsunenari T, Takihata Y, Iwasaki T, Miyata Y, Okamoto K, Kajiwara Y, Shinto E, Tsujimoto H, Yasuda S, Isozaki Y, Yamada S, Yamamoto J, Ueno H, Kishi Y. Sota Y, et al. Among authors: kobayashi k. Mol Clin Oncol. 2021 Jun;14(6):126. doi: 10.3892/mco.2021.2288. Epub 2021 Apr 26. Mol Clin Oncol. 2021. PMID: 33981430 Free PMC article.
12,040 results
You have reached the last available page of results. Please see the User Guide for more information.